MAINZ BIOMED B V's ticker is and the CUSIP is N5436L101. A total of 6 filers reported holding MAINZ BIOMED B V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenwich Investment Management, Inc. | 14,724 | $215,000 | 0.13% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1,445 | $21,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 262 | $4,000 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 500 | $7,000 | 0.00% |
| BARCLAYS PLC | 477 | $7,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 37 | $1,000 | 0.00% |